TY - JOUR AU - Baumeister, S. H. AU - Freeman, G. J. AU - Dranoff, G. AU - Sharpe, A. H. PY - 2016 DA - 2016// TI - Coinhibitory pathways in immunotherapy for Cancer JO - Annu Rev Immunol VL - 34 UR - https://doi.org/10.1146/annurev-immunol-032414-112049 DO - 10.1146/annurev-immunol-032414-112049 ID - Baumeister2016 ER - TY - JOUR AU - Callahan, M. a. r. g. a. r. e. t.  . K. AU - Postow, M. i. c. h. a. e. l.  . A. AU - Wolchok, J. e. d. d.  . D. PY - 2016 DA - 2016// TI - Targeting T Cell Co-receptors for Cancer Therapy JO - Immunity VL - 44 UR - https://doi.org/10.1016/j.immuni.2016.04.023 DO - 10.1016/j.immuni.2016.04.023 ID - Callahan2016 ER - TY - JOUR AU - Schildberg, F. A. AU - Klein, S. R. AU - Freeman, G. J. AU - Sharpe, A. H. PY - 2016 DA - 2016// TI - Coinhibitory pathways in the B7-CD28 ligand-receptor family JO - Immunity VL - 44 UR - https://doi.org/10.1016/j.immuni.2016.05.002 DO - 10.1016/j.immuni.2016.05.002 ID - Schildberg2016 ER - TY - JOUR AU - Selby, M. J. AU - Engelhardt, J. J. AU - Quigley, M. AU - Henning, K. A. AU - Chen, T. AU - Srinivasan, M. PY - 2013 DA - 2013// TI - Anti-CTLA-4 antibodies of IgG2a Isotype enhance antitumor activity through reduction of Intratumoral regulatory T cells JO - Cancer Immunol Res VL - 1 UR - https://doi.org/10.1158/2326-6066.CIR-13-0013 DO - 10.1158/2326-6066.CIR-13-0013 ID - Selby2013 ER - TY - JOUR AU - Simpson, T. R. AU - Li, F. AU - Montalvo-Ortiz, W. AU - Sepulveda, M. A. AU - Bergerhoff, K. AU - Arce, F. PY - 2013 DA - 2013// TI - Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti–CTLA-4 therapy against melanoma JO - J Exp Med VL - 210 UR - https://doi.org/10.1084/jem.20130579 DO - 10.1084/jem.20130579 ID - Simpson2013 ER - TY - JOUR AU - Bowtell, D. D. AU - Böhm, S. AU - Ahmed, A. A. AU - Aspuria, P. -. J. AU - Bast, R. C. AU - Beral, V. PY - 2015 DA - 2015// TI - Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer JO - Nat Rev Cancer VL - 15 UR - https://doi.org/10.1038/nrc4019 DO - 10.1038/nrc4019 ID - Bowtell2015 ER - TY - JOUR AU - Zhang, L. AU - Conejo-Garcia, J. R. AU - Katsaros, D. AU - Gimotty, P. A. AU - Massobrio, M. AU - Regnani, G. PY - 2003 DA - 2003// TI - Intratumoral T cells, recurrence, and survival in epithelial ovarian Cancer JO - N Engl J Med VL - 348 UR - https://doi.org/10.1056/NEJMoa020177 DO - 10.1056/NEJMoa020177 ID - Zhang2003 ER - TY - JOUR AU - Nielsen, J. S. AU - Sahota, R. A. AU - Milne, K. AU - Kost, S. E. AU - Nesslinger, N. J. AU - Watson, P. H. PY - 2012 DA - 2012// TI - CD20+ tumor-infiltrating lymphocytes have an atypical CD27- memory phenotype and together with CD8+ T cells promote favorable prognosis in ovarian Cancer JO - Clin Cancer Res VL - 18 UR - https://doi.org/10.1158/1078-0432.CCR-12-0234 DO - 10.1158/1078-0432.CCR-12-0234 ID - Nielsen2012 ER - TY - JOUR AU - Hamanishi, J. AU - Mandai, M. AU - Ikeda, T. AU - Minami, M. AU - Kawaguchi, A. AU - Murayama, T. PY - 2015 DA - 2015// TI - Safety and antitumor activity of anti-PD-1 antibody, nivolumab, in patients with platinum-resistant ovarian cancer JO - J Clin Oncol VL - 33 UR - https://doi.org/10.1200/JCO.2015.62.3397 DO - 10.1200/JCO.2015.62.3397 ID - Hamanishi2015 ER - TY - JOUR AU - Disis, M. L. AU - Patel, M. R. AU - Pant, S. AU - Infante, J. R. AU - Lockhart, A. C. AU - Kelly, K. PY - 2015 DA - 2015// TI - Avelumab (MSB0010718C), an anti-PD-L1 antibody, in patients with previously treated, recurrent or refractory ovarian cancer: a phase Ib, open-label expansion trial JO - J Clin Oncol VL - 33 UR - https://doi.org/10.1200/jco.2015.33.15_suppl.5509 DO - 10.1200/jco.2015.33.15_suppl.5509 ID - Disis2015 ER - TY - JOUR AU - Varga, A. AU - Piha-Paul, S. A. AU - Ott, P. A. AU - Mehnert, J. M. AU - Berton-Rigaud, D. AU - Johnson, E. A. PY - 2015 DA - 2015// TI - Antitumor activity and safety of pembrolizumab in patients (pts) with PD-L1 positive advanced ovarian cancer: interim results from a phase Ib study JO - J Clin Oncol VL - 33 UR - https://doi.org/10.1200/jco.2015.33.15_suppl.5510 DO - 10.1200/jco.2015.33.15_suppl.5510 ID - Varga2015 ER - TY - JOUR AU - Clouthier, D. L. AU - Lien, S. C. AU - Yang, S. Y. C. AU - Nguyen, L. T. AU - Manem, V. S. K. AU - Gray, D. PY - 2019 DA - 2019// TI - An interim report on the investigator-initiated phase 2 study of pembrolizumab immunological response evaluation ( INSPIRE ) JO - J Immunother Cancer VL - 7 UR - https://doi.org/10.1186/s40425-019-0541-0 DO - 10.1186/s40425-019-0541-0 ID - Clouthier2019 ER - TY - JOUR AU - Podojil, J. o. s. e. p. h. R. AU - Chiang, M. i. n. g. -. Y. i. AU - Ifergan, I. g. a. l. AU - Copeland, R. o. n. a. l. d. AU - Liu, L. i. n. d. a. N. AU - Maloveste, S. e. b. a. s. t. i. e. n. AU - Langermann, S. o. l. o. m. o. n. AU - Liebenson, D. a. v. i. d. AU - Balabanov, R. o. u. m. e. n. AU - Chi, H. o. n. g. b. o. AU - Chen, L. i. e. p. i. n. g. AU - Vignali, D. a. r. i. o. A. A. AU - Miller, S. t. e. p. h. e. n. D. PY - 2018 DA - 2018// TI - B7-H4 Modulates Regulatory CD4+ T Cell Induction and Function via Ligation of a Semaphorin 3a/Plexin A4/Neuropilin-1 Complex JO - The Journal of Immunology VL - 201 UR - https://doi.org/10.4049/jimmunol.1700811 DO - 10.4049/jimmunol.1700811 ID - Podojil2018 ER - TY - JOUR AU - Ohaegbulam, K. C. AU - Liu, W. AU - Jeon, H. AU - Almo, S. C. AU - Zang, X. PY - 2017 DA - 2017// TI - Tumor-expressed immune checkpoint B7x promotes cancer progression and antigen-specific CD8 T cell exhaustion and suppressive innate immune cells JO - Oncotarget VL - 8 UR - https://doi.org/10.18632/oncotarget.21098 DO - 10.18632/oncotarget.21098 ID - Ohaegbulam2017 ER - TY - JOUR AU - MacGregor, H. L. AU - Ohashi, P. S. PY - 2017 DA - 2017// TI - Molecular pathways: evaluating the potential for B7-H4 as an Immunoregulatory target JO - Clin Cancer Res VL - 23 UR - https://doi.org/10.1158/1078-0432.CCR-15-2440 DO - 10.1158/1078-0432.CCR-15-2440 ID - MacGregor2017 ER - TY - JOUR AU - Picarda, E. AU - Ohaegbulam, K. C. AU - Zang, X. PY - 2016 DA - 2016// TI - Molecular pathways: targeting B7-H3 (CD276) for human cancer immunotherapy JO - Clin Cancer Res VL - 22 UR - https://doi.org/10.1158/1078-0432.CCR-15-2428 DO - 10.1158/1078-0432.CCR-15-2428 ID - Picarda2016 ER - TY - JOUR AU - Zhang, X. AU - Fang, C. AU - Zhang, G. AU - Jiang, F. AU - Wang, L. AU - Hou, J. PY - 2017 DA - 2017// TI - Prognostic value of B7-H3 expression in patients with solid tumors: a meta-analysis JO - Oncotarget VL - 8 ID - Zhang2017 ER - TY - JOUR AU - Mak, M. P. AU - Tong, P. AU - Diao, L. AU - Cardnell, R. J. AU - Gibbons, D. L. AU - William, W. N. PY - 2015 DA - 2015// TI - A patient-derived, pan-Cancer EMT signature identifies global molecular alterations and immune target enrichment following epithelial-to-Mesenchymal transition JO - Clin Cancer Res VL - 22 UR - https://doi.org/10.1158/1078-0432.CCR-15-0876 DO - 10.1158/1078-0432.CCR-15-0876 ID - Mak2015 ER - TY - JOUR AU - Li, Y. AU - Yang, X. AU - Wu, Y. AU - Zhao, K. AU - Ye, Z. AU - Zhu, J. PY - 2017 DA - 2017// TI - B7-H3 promotes gastric cancer cell migration and invasion JO - Oncotarget VL - 8 ID - Li2017 ER - TY - JOUR AU - Zhang, C. AU - Zhang, Z. AU - Li, F. AU - Shen, Z. AU - Qiao, Y. AU - Li, L. PY - 2018 DA - 2018// TI - Large-scale analysis reveals the specific clinical and immune features of B7-H3 in glioma JO - Oncoimmunology VL - 7 UR - https://doi.org/10.1080/2162402X.2018.1461304 DO - 10.1080/2162402X.2018.1461304 ID - Zhang2018 ER - TY - JOUR AU - Lemke, D. AU - Pfenning, P. -. N. AU - Sahm, F. AU - Klein, A. -. C. AU - Kempf, T. AU - Warnken, U. PY - 2012 DA - 2012// TI - Costimulatory protein 4IgB7H3 drives the malignant phenotype of glioblastoma by mediating immune escape and invasiveness JO - Clin Cancer Res VL - 18 UR - https://doi.org/10.1158/1078-0432.CCR-11-0880 DO - 10.1158/1078-0432.CCR-11-0880 ID - Lemke2012 ER - TY - JOUR AU - Zang, X. AU - Sullivan, P. S. AU - Soslow, R. A. AU - Waitz, R. AU - Reuter, V. E. AU - Wilton, A. PY - 2010 DA - 2010// TI - Tumor associated endothelial expression of B7-H3 predicts survival in ovarian carcinomas JO - Mod Pathol VL - 23 UR - https://doi.org/10.1038/modpathol.2010.95 DO - 10.1038/modpathol.2010.95 ID - Zang2010 ER - TY - JOUR AU - Ingebrigtsen, V. A. AU - Boye, K. AU - Tekle, C. AU - Nesland, J. M. AU - Flatmark, K. AU - Fodstad, O. PY - 2012 DA - 2012// TI - B7-H3 expression in colorectal cancer: nuclear localization strongly predicts poor outcome in colon cancer JO - Int J Cancer VL - 131 UR - https://doi.org/10.1002/ijc.27566 DO - 10.1002/ijc.27566 ID - Ingebrigtsen2012 ER - TY - JOUR AU - Brunner, A. AU - Hinterholzer, S. AU - Riss, P. AU - Heinze, G. AU - Brustmann, H. PY - 2012 DA - 2012// TI - Immunoexpression of B7-H3 in endometrial cancer: relation to tumor T-cell infiltration and prognosis JO - Gynecol Oncol VL - 124 UR - https://doi.org/10.1016/j.ygyno.2011.09.012 DO - 10.1016/j.ygyno.2011.09.012 ID - Brunner2012 ER - TY - JOUR AU - Crispen, P. L. AU - Sheinin, Y. AU - Roth, T. J. AU - Lohse, C. M. AU - Kuntz, S. M. AU - Frigola, X. PY - 2008 DA - 2008// TI - Tumor cell and tumor vasculature expression of B7-H3 predict survival in clear cell renal cell carcinoma JO - Clin Cancer Res VL - 14 UR - https://doi.org/10.1158/1078-0432.CCR-08-0536 DO - 10.1158/1078-0432.CCR-08-0536 ID - Crispen2008 ER - TY - JOUR AU - Costa, A. AU - Kieffer, Y. AU - Scholer-Dahirel, A. AU - Pelon, F. AU - Bourachot, B. AU - Cardon, M. PY - 2018 DA - 2018// TI - Fibroblast heterogeneity and immunosuppressive environment in human breast Cancer JO - Cancer Cell VL - 33 UR - https://doi.org/10.1016/j.ccell.2018.01.011 DO - 10.1016/j.ccell.2018.01.011 ID - Costa2018 ER - TY - JOUR AU - Gao, J. AU - Aksoy, B. A. AU - Dogrusoz, U. AU - Dresdner, G. AU - Gross, B. AU - Sumer, S. O. AU - Sun, Y. AU - Jacobsen, A. AU - Sinha, R. AU - Larsson, E. AU - Cerami, E. AU - Sander, C. AU - Schultz, N. PY - 2013 DA - 2013// TI - Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal JO - Science Signaling VL - 6 UR - https://doi.org/10.1126/scisignal.2004088 DO - 10.1126/scisignal.2004088 ID - Gao2013 ER - TY - JOUR AU - Cerami, E. AU - Gao, J. AU - Dogrusoz, U. AU - Gross, B. E. AU - Sumer, S. O. AU - Aksoy, B. A. PY - 2012 DA - 2012// TI - The cBio Cancer genomics portal: an open platform for exploring multidimensional cancer genomics data JO - Cancer Discov VL - 2 UR - https://doi.org/10.1158/2159-8290.CD-12-0095 DO - 10.1158/2159-8290.CD-12-0095 ID - Cerami2012 ER - TY - JOUR AU - Petroff, M. G. AU - Kharatyan, E. AU - Torry, D. S. AU - Holets, L. PY - 2005 DA - 2005// TI - The Immunomodulatory proteins B7-DC, B7-H2, and B7-H3 are differentially expressed across gestation in the human placenta JO - Am J Pathol VL - 167 UR - https://doi.org/10.1016/S0002-9440(10)62990-2 DO - 10.1016/S0002-9440(10)62990-2 ID - Petroff2005 ER - TY - JOUR AU - Shi, L. AU - Chen, L. AU - Wu, C. AU - Zhu, Y. AU - Xu, B. AU - Zheng, X. PY - 2016 DA - 2016// TI - PD-1 blockade boosts radiofrequency ablation-elicited adaptive immune responses against tumor JO - Clin Cancer Res VL - 22 UR - https://doi.org/10.1158/1078-0432.CCR-15-1352 DO - 10.1158/1078-0432.CCR-15-1352 ID - Shi2016 ER - TY - JOUR AU - Liu, Z. i. x. i. n. g. AU - Zhang, W. e. n. l. i. n. g. AU - Phillips, J. o. s. h. u. a. B. AU - Arora, R. i. t. u. AU - McClellan, S. t. e. v. e. n. AU - Li, J. i. a. n. g. f. e. n. g. AU - Kim, J. i. n. -. H. w. a. n. AU - Sobol, R. o. b. e. r. t. W. AU - Tan, M. i. n. g. PY - 2018 DA - 2018// TI - Immunoregulatory protein B7-H3 regulates cancer stem cell enrichment and drug resistance through MVP-mediated MEK activation JO - Oncogene VL - 38 UR - https://doi.org/10.1038/s41388-018-0407-9 DO - 10.1038/s41388-018-0407-9 ID - Liu2018 ER - TY - JOUR AU - Kalluri, R. PY - 2016 DA - 2016// TI - The biology and function of fibroblasts in cancer JO - Nat Rev Cancer VL - 16 UR - https://doi.org/10.1038/nrc.2016.73 DO - 10.1038/nrc.2016.73 ID - Kalluri2016 ER - TY - JOUR AU - Wu, J. AU - Liang, C. AU - Chen, M. AU - Su, W. PY - 2016 DA - 2016// TI - Association between tumor-stroma ratio and prognosis in solid tumor patients: a systematic review and meta-analysis JO - Oncotarget VL - 7 ID - Wu2016 ER - TY - JOUR AU - Smith, J. B. AU - Lanitis, E. AU - Dangaj, D. AU - Buza, E. AU - Poussin, M. AU - Stashwick, C. PY - 2016 DA - 2016// TI - Tumor regression and delayed onset toxicity following B7-H4 CAR T cell therapy JO - Mol Ther VL - 24 UR - https://doi.org/10.1038/mt.2016.149 DO - 10.1038/mt.2016.149 ID - Smith2016 ER - TY - JOUR AU - Hansen, J. M. AU - Coleman, R. L. AU - Sood, A. K. PY - 2017 DA - 2017// TI - Targeting the tumor microenvironment in ovarian Cancer JO - Eur J Cancer VL - 56 UR - https://doi.org/10.1016/j.ejca.2015.12.016 DO - 10.1016/j.ejca.2015.12.016 ID - Hansen2017 ER - TY - JOUR AU - Mariathasan, S. AU - Turley, S. J. AU - Nickles, D. AU - Castiglioni, A. AU - Yuen, K. AU - Wang, Y. PY - 2018 DA - 2018// TI - TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells JO - Nature VL - 554 UR - https://doi.org/10.1038/nature25501 DO - 10.1038/nature25501 ID - Mariathasan2018 ER - TY - JOUR AU - Altan, M. AU - Pelekanou, V. AU - Schalper, K. A. AU - Toki, M. AU - Gaule, P. AU - Syrigos, K. PY - 2017 DA - 2017// TI - B7-H3 expression in NSCLC and its association with B7-H4, PD-L1 and tumor-infiltrating lymphocytes JO - Clin Cancer Res VL - 23 UR - https://doi.org/10.1158/1078-0432.CCR-16-3107 DO - 10.1158/1078-0432.CCR-16-3107 ID - Altan2017 ER - TY - JOUR AU - Finak, G. AU - Bertos, N. AU - Pepin, F. AU - Sadekova, S. AU - Souleimanova, M. AU - Zhao, H. PY - 2008 DA - 2008// TI - Stromal gene expression predicts clinical outcome in breast cancer JO - Nat Med VL - 14 UR - https://doi.org/10.1038/nm1764 DO - 10.1038/nm1764 ID - Finak2008 ER - TY - JOUR AU - Chen, G. M. AU - Kannan, L. AU - Geistlinger, L. AU - Kofia, V. AU - Safikhani, Z. AU - Gendoo, D. M. A. PY - 2018 DA - 2018// TI - Consensus on molecular subtypes of high-grade serous ovarian carcinoma JO - Clin Cancer Res VL - 24 ID - Chen2018 ER - TY - JOUR AU - Farmer, P. AU - Bonnefoi, H. AU - Anderle, P. AU - Cameron, D. AU - Wirapati, P. AU - Becette, V. PY - 2009 DA - 2009// TI - A stroma-related gene signature predicts resistance to neoadjuvant chemotherapy in breast cancer JO - Nat Med VL - 15 UR - https://doi.org/10.1038/nm.1908 DO - 10.1038/nm.1908 ID - Farmer2009 ER - TY - JOUR AU - Saleh, M. N. AU - Goldman, S. J. AU - LoBuglio, A. F. AU - Beall, A. C. AU - Sabio, H. AU - McCord, M. C. PY - 1995 DA - 1995// TI - CD16+ monocytes in patients with Cancer: spontaneous elevation and pharmacologic induction by recombinant human macrophage Colony-stimulating factor JO - Blood VL - 85 UR - https://doi.org/10.1182/blood.V85.10.2910.bloodjournal85102910 DO - 10.1182/blood.V85.10.2910.bloodjournal85102910 ID - Saleh1995 ER - TY - JOUR AU - Romano, E. AU - Kusio-Kobialka, M. AU - Foukas, P. G. AU - Baumgaertner, P. AU - Meyer, C. AU - Ballabeni, P. PY - 2015 DA - 2015// TI - Ipilimumab-dependent cell-mediated cytotoxicity of regulatory T cells ex vivo by nonclassical monocytes in melanoma patients JO - Proc Natl Acad Sci U S A VL - 112 UR - https://doi.org/10.1073/pnas.1417320112 DO - 10.1073/pnas.1417320112 ID - Romano2015 ER - TY - JOUR AU - Phillips, J. H. AU - Chang, C. AU - Lanier, L. L. PY - 1991 DA - 1991// TI - Platelet-induced expression of Fcy RIII (CD16) on human monocytes JO - Eur J Immunol VL - 21 UR - https://doi.org/10.1002/eji.1830210406 DO - 10.1002/eji.1830210406 ID - Phillips1991 ER - TY - JOUR AU - Al-Rashed, F. AU - Ahmad, Z. AU - Iskandar, M. A. AU - Tuomilehto, J. AU - Al-Mulla, F. AU - Ahmad, R. PY - 2019 DA - 2019// TI - TNF-α induces a pro-inflammatory phenotypic shift in monocytes through ACSL1: relevance to metabolic inflammation JO - Cell Physiol Biochem VL - 52 UR - https://doi.org/10.33594/000000028 DO - 10.33594/000000028 ID - Al-Rashed2019 ER - TY - JOUR AU - Victor, A. R. AU - Weigel, C. AU - Scoville, S. D. AU - Chan, W. K. AU - Chatman, K. AU - Nemer, M. M. PY - 2018 DA - 2018// TI - Epigenetic and posttranscriptional regulation of CD16 expression during human NK cell development JO - J Immunol VL - 200 UR - https://doi.org/10.4049/jimmunol.1701128 DO - 10.4049/jimmunol.1701128 ID - Victor2018 ER - TY - JOUR AU - Xu, H. AU - Sun, Q. AU - Lu, L. AU - Luo, F. AU - Zhou, L. AU - Liu, J. PY - 2017 DA - 2017// TI - MicroRNA-218 acts by repressing TNFR1-mediated activation of NF-κB, which is involved in MUC5AC hyper-production and inflammation in smoking-induced bronchiolitis of COPD JO - Toxicol Lett VL - 280 UR - https://doi.org/10.1016/j.toxlet.2017.08.079 DO - 10.1016/j.toxlet.2017.08.079 ID - Xu2017 ER - TY - JOUR AU - Antonelli, L. R. V. AU - Leoratti, F. M. S. AU - Costa, P. A. C. AU - Rocha, B. C. AU - Diniz, S. Q. AU - Tada, M. S. PY - 2014 DA - 2014// TI - The CD14+CD16+ inflammatory monocyte subset displays increased mitochondrial activity and effector function during acute plasmodium vivax malaria JO - PLoS Pathog VL - 10 UR - https://doi.org/10.1371/journal.ppat.1004393 DO - 10.1371/journal.ppat.1004393 ID - Antonelli2014 ER - TY - JOUR AU - Belge, K. -. U. AU - Dayyani, F. AU - Horelt, A. AU - Siedlar, M. AU - Frankenberger, M. AU - Frankenberger, B. PY - 2002 DA - 2002// TI - The Proinflammatory CD14+CD16+DR++ monocytes are a major source of TNF JO - J Immunol VL - 168 UR - https://doi.org/10.4049/jimmunol.168.7.3536 DO - 10.4049/jimmunol.168.7.3536 ID - Belge2002 ER - TY - JOUR AU - Romee, R. AU - Foley, B. AU - Lenvik, T. AU - Wang, Y. AU - Zhang, B. AU - Ankarlo, D. PY - 2013 DA - 2013// TI - NK cell CD16 surface expression and function is regulated by a disintegrin and metalloprotease-17 (ADAM17) JO - Blood VL - 121 UR - https://doi.org/10.1182/blood-2012-04-425397 DO - 10.1182/blood-2012-04-425397 ID - Romee2013 ER - TY - JOUR AU - Miller, M. A. AU - Sullivan, R. J. AU - Lauffenburger, D. A. PY - 2017 DA - 2017// TI - Molecular pathways: receptor ectodomain shedding in treatment, resistance, and monitoring of cancer JO - Clin Cancer Res VL - 23 UR - https://doi.org/10.1158/1078-0432.CCR-16-0869 DO - 10.1158/1078-0432.CCR-16-0869 ID - Miller2017 ER - TY - JOUR AU - Sancho, D. AU - Mourão-Sá, D. AU - Joffre, O. P. AU - Schulz, O. AU - Rogers, N. C. AU - Pennington, D. J. PY - 2008 DA - 2008// TI - Tumor therapy in mice via antigen targeting to a novel, DC-restricted C-type lectin JO - J Clin Invest VL - 118 UR - https://doi.org/10.1172/JCI34584 DO - 10.1172/JCI34584 ID - Sancho2008 ER - TY - JOUR AU - Schreibelt, G. AU - Klinkenberg, L. J. J. AU - Cruz, L. J. AU - Tacken, P. J. AU - Tel, J. AU - Kreutz, M. PY - 2012 DA - 2012// TI - The C-type lectin receptor CLEC9A mediates antigen uptake and (cross-)presentation by human blood BDCA3+ myeloid dendritic cells JO - Blood VL - 119 UR - https://doi.org/10.1182/blood-2011-08-373944 DO - 10.1182/blood-2011-08-373944 ID - Schreibelt2012 ER - TY - JOUR AU - Herbst, R. S. AU - Soria, J. C. AU - Kowanetz, M. AU - Fine, G. D. AU - Hamid, O. AU - Gordon, M. S. PY - 2014 DA - 2014// TI - Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients JO - Nature VL - 515 UR - https://doi.org/10.1038/nature14011 DO - 10.1038/nature14011 ID - Herbst2014 ER - TY - JOUR AU - Lin, H. AU - Wei, S. AU - Hurt, E. M. AU - Green, M. D. AU - Zhao, L. AU - Vatan, L. PY - 2018 DA - 2018// TI - Host expression of PD-L1 determines efficacy of PD-L1 pathway blockade–mediated tumor regression JO - J Clin Invest VL - 128 UR - https://doi.org/10.1172/JCI96113 DO - 10.1172/JCI96113 ID - Lin2018 ER - TY - JOUR AU - Flies, D. B. AU - Higuchi, T. AU - Harris, J. C. AU - Jha, V. AU - Gimotty, P. A. AU - Adams, S. F. PY - 2016 DA - 2016// TI - Immune checkpoint blockade reveals the stimulatory capacity of tumor-associated CD103+ dendritic cells in late-stage ovarian cancer JO - Oncoimmunology VL - 5 UR - https://doi.org/10.1080/2162402X.2016.1185583 DO - 10.1080/2162402X.2016.1185583 ID - Flies2016 ER - TY - JOUR AU - Hagemann, A. R. AU - Hagemann, I. S. AU - Cadungog, M. AU - Hwang, W. T. AU - Patel, P. AU - Lal, P. PY - 2011 DA - 2011// TI - Tissue-based immune monitoring II: multiple tumor sites reveal immunologic homogeneity in serous ovarian carcinoma JO - Cancer Biol Ther VL - 12 UR - https://doi.org/10.4161/cbt.12.4.16908 DO - 10.4161/cbt.12.4.16908 ID - Hagemann2011 ER - TY - JOUR AU - Dötzer, K. AU - Schlüter, F. AU - Schoenberg, M. B. AU - Bazhin, A. V. AU - Koch, F. E. AU - Schnelzer, A. PY - 2019 DA - 2019// TI - Immune heterogeneity between primary tumors and corresponding metastatic lesions and response to platinum therapy in primary ovarian Cancer JO - Cancers (Basel) VL - 11 UR - https://doi.org/10.3390/cancers11091250 DO - 10.3390/cancers11091250 ID - Dötzer2019 ER - TY - STD TI - Zhang AW, Mcpherson A, Milne K, Kroeger DR, Hamilton PT, Miranda A, et al. Interfaces of malignant and immunologic clonal dynamics in ovarian cancer. Cell. 2018;173:1755-69. ID - ref58 ER - TY - JOUR AU - Neff, R. T. AU - Senter, L. AU - Salani, R. PY - 2017 DA - 2017// TI - BRCA mutation in ovarian cancer: testing, implications and treatment considerations JO - Ther Adv Med Oncol VL - 9 UR - https://doi.org/10.1177/1758834017714993 DO - 10.1177/1758834017714993 ID - Neff2017 ER - TY - JOUR AU - Moore, K. N. AU - Raza, M. AU - Matulonis, U. A. PY - 2018 DA - 2018// TI - The poly (ADP ribose) polymerase inhibitor niraparib: management of toxicities JO - Gynecol Oncol VL - 149 UR - https://doi.org/10.1016/j.ygyno.2018.01.011 DO - 10.1016/j.ygyno.2018.01.011 ID - Moore2018 ER -